Healthcare provider profile · identity verified

Douglas Albert Woerner, DO

Family Practice · LAUREL, MT · NPI 1649437328

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	475	128
Atorvastatin Calcium	Atorvastatin Calcium	465	133
Losartan Potassium	Losartan Potassium	360	101
Levothyroxine Sodium	Levothyroxine Sodium	311	85
Omeprazole	Omeprazole	298	84
Amlodipine Besylate	Amlodipine Besylate	278	82
Simvastatin	Simvastatin	191	56
Hydrochlorothiazide	Hydrochlorothiazide	181	56
Metformin Hcl	Metformin Hcl	178	51
Pantoprazole Sodium	Pantoprazole Sodium	177	51
Metformin Hcl Er	Metformin Hcl	170	52
Tamsulosin Hcl	Tamsulosin Hcl	165	56
Gabapentin	Gabapentin	164	51
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	159	39
Metoprolol Succinate	Metoprolol Succinate	156	46
Sertraline Hcl	Sertraline Hcl	148	41
Metoprolol Tartrate	Metoprolol Tartrate	139	37
Meloxicam	Meloxicam	134	34
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	128	30
Furosemide	Furosemide	127	33
Potassium Chloride	Potassium Chloride	126	34
Allopurinol	Allopurinol	122	29
Pravastatin Sodium	Pravastatin Sodium	112	29
Tramadol Hcl	Tramadol Hcl	104	23
Rosuvastatin Calcium	Rosuvastatin Calcium	103	31
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	95	29
Eliquis	Apixaban	86	24
Ozempic	Semaglutide	81	18
Zolpidem Tartrate	Zolpidem Tartrate	76	20
Duloxetine Hcl	Duloxetine Hcl	73	18
Citalopram Hbr	Citalopram Hydrobromide	70	15
Trazodone Hcl	Trazodone Hcl	70	19
Fluoxetine Hcl	Fluoxetine Hcl	69	18
Ropinirole Hcl	Ropinirole Hcl	69	14
Ventolin Hfa	Albuterol Sulfate	69	18
Albuterol Sulfate Hfa	Albuterol Sulfate	67	26
Lorazepam	Lorazepam	67	18
Spironolactone	Spironolactone	67	15
Oxycodone Hcl	Oxycodone Hcl	65	12
Clonazepam	Clonazepam	62	15
Oxybutynin Chloride Er	Oxybutynin Chloride	61	16
Carvedilol	Carvedilol	59	15
Prednisone	Prednisone	53	35
Bupropion Xl	Bupropion Hcl	50	13
Escitalopram Oxalate	Escitalopram Oxalate	47	13
Finasteride	Finasteride	47	15
Alprazolam	Alprazolam	45	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	45	12
Alendronate Sodium	Alendronate Sodium	44	13
Celecoxib	Celecoxib	41	suppressed
Glimepiride	Glimepiride	41	15
Amitriptyline Hcl	Amitriptyline Hcl	40	11
Jardiance	Empagliflozin	40	suppressed
Buspirone Hcl	Buspirone Hcl	38	11
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	suppressed
Warfarin Sodium	Warfarin Sodium	36	suppressed
Methylprednisolone	Methylprednisolone	35	22
Temazepam	Temazepam	35	suppressed
Trulicity	Dulaglutide	34	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	33	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Pregabalin	Pregabalin	31	suppressed
Fluticasone Propionate	Fluticasone Propionate	30	16
Quetiapine Fumarate	Quetiapine Fumarate	29	suppressed
Methocarbamol	Methocarbamol	28	15
Farxiga	Dapagliflozin Propanediol	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	suppressed
Atenolol	Atenolol	26	suppressed
Cephalexin	Cephalexin	26	16
Famotidine	Famotidine	26	suppressed
Nifedipine Er	Nifedipine	26	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Glyburide	Glyburide	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	25	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Novolog Flexpen	Insulin Aspart	24	suppressed
Aripiprazole	Aripiprazole	23	suppressed
Glipizide	Glipizide	23	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Montelukast Sodium	Montelukast Sodium	23	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	22	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	16
Levetiracetam	Levetiracetam	20	suppressed
Azithromycin	Azithromycin	19	17
Ezetimibe	Ezetimibe	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Baclofen	Baclofen	17	suppressed
Clopidogrel	Clopidogrel Bisulfate	17	suppressed
Telmisartan	Telmisartan	17	suppressed
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	16	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	16	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Indomethacin	Indomethacin	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	12
Estradiol	Estradiol	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Primidone	Primidone	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Desmopressin Acetate	Desmopressin Acetate	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Xifaxan	Rifaximin	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error